These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 17761715)

  • 1. Occasional FDG PET recognition of in situ breast cancer.
    Vincenzi B; Calvieri A; Santini D; Altomare V; Tonini G
    Ann Oncol; 2007 Sep; 18(9):1584-5. PubMed ID: 17761715
    [No Abstract]   [Full Text] [Related]  

  • 2. Invasive lobular carcinoma in a patient with synchronous ductal carcinoma in situ: detection with MR imaging.
    Cooney BS; Orel SG; Schnall MD; Troupin RH
    AJR Am J Roentgenol; 1994 Jun; 162(6):1318-20. PubMed ID: 8191990
    [No Abstract]   [Full Text] [Related]  

  • 3. Lobular neoplasia of the breast revisited with emphasis on the role of E-cadherin immunohistochemistry.
    Wells JM; Pipa J; Shin SJ
    Am J Surg Pathol; 2014 Mar; 38(3):434-5. PubMed ID: 24441664
    [No Abstract]   [Full Text] [Related]  

  • 4. In situ and infiltrating ductal carcinoma arising in a breast hamartoma.
    Mester J; Simmons RM; Vazquez MF; Rosenblatt R
    AJR Am J Roentgenol; 2000 Jul; 175(1):64-6. PubMed ID: 10882247
    [No Abstract]   [Full Text] [Related]  

  • 5. Carcinoma in situ involving sclerosing adenosis.
    Fechner RE
    Histopathology; 1996 Jun; 28(6):570. PubMed ID: 8803606
    [No Abstract]   [Full Text] [Related]  

  • 6. [Carcinoma in situ and invasive carcinoma within a breast hamartoma].
    Franco Uliaque C; Pardo Berdun FJ
    Radiologia; 2010; 52(5):487-8. PubMed ID: 20863538
    [No Abstract]   [Full Text] [Related]  

  • 7. [Carcinoma in situ. Prognostic factors].
    Trojani M
    Arch Anat Cytol Pathol; 1994; 42(5):234-50. PubMed ID: 7872815
    [No Abstract]   [Full Text] [Related]  

  • 8. Synchronous primary malignant tumors of the breast, caecum and sigma. Case report.
    Anania G; Santini M; Marzetti A; Scagliarini L; Vedana L; Resta G; Cavallesco G
    G Chir; 2012; 33(11-12):409-10. PubMed ID: 23140927
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CE-Magnetic Resonance Mammography for the evaluation of the contralateral breast in patients with diagnosed breast cancer.
    Pediconi F; Venditti F; Padula S; Roselli A; Moriconi E; Giacomelli L; Catalano C; Passariello R
    Radiol Med; 2005; 110(1-2):61-8. PubMed ID: 16163140
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Breast procedures guided by magnetic resonance imaging.
    David J; Trop I; Lalonde L
    Can Assoc Radiol J; 2005 Dec; 56(5):309-18. PubMed ID: 16579025
    [No Abstract]   [Full Text] [Related]  

  • 11. Ten-year follow-up of breast carcinoma in situ in Connecticut.
    Ward BA; McKhann CF; Ravikumar TS
    Arch Surg; 1992 Dec; 127(12):1392-5. PubMed ID: 1365682
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Positron emission tomography combined with computed tomography overturns the initial treatment plan].
    Pecking AP
    Rev Prat; 2004 Apr; 54(8):839. PubMed ID: 15274455
    [No Abstract]   [Full Text] [Related]  

  • 13. [A case of low grade ductal carcinoma in situ of the breast with difficulties in making the preoperative diagnosis after detection by FDG-PET].
    Tsurudome Y; Katsuki T; Konishi T; Nagata J; Inoue Y; Nagata T; Shibao K; Higure A; Hirata K; Nakayama Y; Okamoto K; Nagata N; Yamaguchi K
    J UOEH; 2008 Sep; 30(3):321-8. PubMed ID: 18783013
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bilateral breast carcinoma- a rare case report.
    Dalal AK; Gupta A; Singal R; Dalal U; Attri AK; Jain P; Sharma A; Gupta S
    J Med Life; 2011; 4(1):94-6. PubMed ID: 21505580
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A case of metastatic lobular breast carcinoma with detection of the primary tumor after ten years.
    Kobayashi T; Adachi S; Matsuda Y; Tominaga S
    Breast Cancer; 2007; 14(3):333-6. PubMed ID: 17690515
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Breast cancer: atlas].
    Thibault F; Benamor M; Tardivon A
    Rev Prat; 2004 Apr; 54(8):837-8, 840. PubMed ID: 15274454
    [No Abstract]   [Full Text] [Related]  

  • 17. Management of lobular carcinoma in situ and ductal carcinoma in situ of the breast.
    Wood WC
    Semin Oncol; 1996 Aug; 23(4):446-52. PubMed ID: 8757271
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of fine-needle aspiration cytology and core biopsy in the diagnosis of proliferative and atypical breast lesions.
    Maygarden SJ
    Anat Pathol; 1997; 2():165-96. PubMed ID: 9575375
    [No Abstract]   [Full Text] [Related]  

  • 19. [Therapeutic problems posed by sub-clinical breast cancers].
    Espié M
    Contracept Fertil Sex; 1999 Apr; 27(4):298-305. PubMed ID: 10349773
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MR is/is not a useful diagnostic tool for breast cancer management.
    Van Goethem M; Verslegers I; Biltjes I; Parizel PM
    Acta Chir Belg; 2007 Jun; 107(3):267-70. PubMed ID: 17685251
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.